Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > History Repeats

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on Nov 08, 2023 4:40pm

125 Views

Post# 35724579

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:History Repeats

Haha don't get upset sweetie it's all just online chat, no need to get emotional.

I think you'd back up off your tough guy talk and maybe be a little more pleasant.

Should we get t-shirts and see if we can maybe televise it for Wallstreet bets too? Just on the % change from today idiot, doesn't have to be complicated.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing